High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients

被引：118
|
作者：
Pisani, A [1 ]
Fezza, F
Galati, S
Battista, N
Napolitano, S
Finazzi-Agró, A
Bernardi, G
Brusa, L
Pierantozzi, M
Stanzione, P
Maccarrone, M
机构：
[1] Univ Roma Tor Vergata, Neurol Clin, Dept Neurosci, Rome, Italy
[2] IRCCS, Santa Lucia Fdn, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy
[4] Univ Teramo, Dept Biochem Sci, Rome, Italy
[5] IRCCS, Ctr Expt Neurobiol C Mondino, Rome, Italy
来源：
ANNALS OF NEUROLOGY | 2005年 / 57卷 / 05期
关键词：
D O I：
10.1002/ana.20462
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：777 / 779
页数：3
相关论文
共 50 条
  • [21] beta-Carbolinium cations, endogenous MPP(+) analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease
    Matsubara, K
    Kobayashi, S
    Kobayashi, Y
    Yamashita, K
    Koide, H
    Hatta, M
    Iwamoto, K
    Tanaka, O
    Kimura, K
    NEUROLOGY, 1995, 45 (12) : 2240 - 2245
  • [22] Altered Cerebrospinal Fluid Levels of α-Synuclein and Aβ in Parkinson Disease
    Kotzbauer, Paul T.
    Buddhala, Chandana
    Campbell, Meghan C.
    Perlmutter, Joel S.
    ANNALS OF NEUROLOGY, 2013, 74 : S42 - S42
  • [23] Cerebrospinal fluid A levels correlate with structural brain changes in Parkinson's disease
    Beyer, Mona K.
    Alves, Guido
    Hwang, Kristy S.
    Babakchanian, Sona
    Bronnick, Kolbjorn S.
    Chou, Yi-Yu
    Dalaker, Turi O.
    Kurz, Martin W.
    Larsen, Jan P.
    Somme, Johanne H.
    Thompson, Paul M.
    Tysnes, Ole-Bjorn
    Apostolova, Liana G.
    MOVEMENT DISORDERS, 2013, 28 (03) : 302 - 310
  • [24] Cerebrospinal Fluid Levels of Chromogranin A in Parkinson's Disease and Multiple System Atrophy
    Kaiserova, Michaela
    Chudackova, Monika
    Mensikova, Katerina
    Vastik, Miroslav
    Kurcova, Sandra
    Prikrylova Vranova, Hana
    Stejskal, David
    Kanovsky, Petr
    BRAIN SCIENCES, 2021, 11 (02) : 1 - 6
  • [25] Polyunsaturated fatty acid levels in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy
    Lee, Phil Hyu
    Lee, Gwang
    Paik, Man-Jeong
    MOVEMENT DISORDERS, 2008, 23 (02) : 309 - 310
  • [26] Mini Review: Correlations of Cognitive Domains With Cerebrospinal Fluid α-Synuclein Levels in Patients With Parkinson's Disease
    Murakami, Hidetomo
    Ono, Kenjiro
    Shiraishi, Tomotaka
    Umehara, Tadashi
    Omoto, Shusaku
    Iguchi, Yasuyuki
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 12
  • [27] Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naive Patients with Parkinson's Disease
    Park, Min Jeong
    Cheon, Sang-Myung
    Bee, Hye-Ran
    Kim, Sang-Ho
    Kim, Jae Woo
    JOURNAL OF CLINICAL NEUROLOGY, 2011, 7 (04): : 215 - 222
  • [28] Alpha-synuclein levels in the cerebrospinal fluid of patients with Parkinson's disease and atypical parkinsonian disorders
    Constantinescu, R.
    Mondello, S.
    Khadim, L.
    Jeromin, A.
    MOVEMENT DISORDERS, 2013, 28 : S320 - S320
  • [29] ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson's disease
    Fernandez-Espejo, Emilio
    Rodriguez de Fonseca, Fernando
    Suarez, Juan
    Gonzalez-Aparicio, Ramiro
    Santurtun, Ana
    PARKINSONISM & RELATED DISORDERS, 2021, 88 : 3 - 9
  • [30] Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease
    Shukla, R.
    Rajani, M.
    Srivastava, N.
    Barthwal, M. K.
    Dikshit, M.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2006, 116 (12) : 1391 - 1402
12345